ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Ann Thorac Surg 2000;69:1730-1731
© 2000 The Society of Thoracic Surgeons


Discussion

Discussion

DR MICHAEL J. MACK (Dallas, TX): President Kouchoukos, Dr Pairolero. I would like to congratulate Dr Kshettry on his presentation and acknowledge the pioneering work of the Minneapolis group in cardiac surgery. I appreciate Dr Kshettry forwarding me a copy of his manuscript for review prior to this meeting.

Evaluation of any new procedure begins first with historical analysis, then registries followed by the design of this study, that is, comparison of contemporaneous cohorts. Further validation includes matched cohorts and the most rigorous controlled, prospective, randomized trials. I would propose that on the basis of the design and methodology of this study, the conclusions of no benefit or minimal benefit are premature.

What are the possible reasons that no greater benefit could be demonstrated from off-pump surgery? It is possible there really is no significant benefit, or there really is a benefit, and this will become more evident with time. There are only 135 patients in the off-pump group. With a low incidence of complication in both groups, power analysis would indicate the necessity of a larger study group to demonstrate differences between the two groups. The predicted risk was higher in the off-pump group, but the mortality results are not risk adjusted. Without risk adjustment the outcomes are not strictly comparable. It is also possible that high-risk subgroups that would receive benefit were not examined. Indeed, Dr Arom from your group recently presented a paper demonstrating a benefit from OPCAB in high-risk patients. If the groups that were most likely to receive benefit were examined independently, perhaps greater benefit could be defined.

Another conceivable reason is that the outcomes in both groups benefited from the selection of high-risk patients into off-pump surgery. If off-pump surgery is indeed most beneficial in high-risk patients, then improved outcomes in both groups would . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Br J AnaesthHome page
P.-G. Chassot, P. van der Linden, M. Zaugg, X. M. Mueller, and D. R. Spahn
Off-pump coronary artery bypass surgery: physiology and anaesthetic management{dagger}
Br. J. Anaesth., March 1, 2004; 92(3): 400 - 413.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.